ストックスクリーナーアプリを入手
1.11
5.13%
-0.06
アフターアワーズ：
1.11
前日終値:
$1.17
開ける：
$1.19
24時間の取引高:
4.28M
Relative Volume:
1.43
時価総額：
$133.52M
収益：
-
当期純損益:
$-93.61M
株価収益率:
-0.5261
EPS:
-2.11
ネットキャッシュフロー:
$-71.16M
1週間 パフォーマンス:
+17.13%
1か月 パフォーマンス:
+88.46%
6か月 パフォーマンス:
+45.86%
1年 パフォーマンス:
-5.13%
1日の値動き範囲:
$1.11
$1.2799
1週間の範囲:
$0.943
$1.2799
52週間の値動き範囲:
$0.5062
$1.35
Immunic Inc Stock (IMUX) Company Profile
Compare IMUX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
1.11 | 140.73M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-07 | 開始されました | Roth Capital | Buy |
| 2025-09-29 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-25 | 開始されました | William Blair | Outperform |
| 2024-11-25 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-09 | 再開されました | Leerink Partners | Outperform |
| 2024-08-27 | 開始されました | B. Riley Securities | Buy |
| 2022-10-21 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | 再開されました | H.C. Wainwright | Buy |
| 2021-04-15 | 開始されました | Aegis Capital | Buy |
| 2021-03-24 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-10-02 | 開始されました | SVB Leerink | Outperform |
| 2020-08-26 | 開始されました | Piper Sandler | Overweight |
| 2020-08-07 | 再開されました | ROTH Capital | Buy |
| 2020-07-20 | 開始されました | BMO Capital Markets | Outperform |
| 2020-06-05 | 開始されました | Wedbush | Outperform |
| 2020-05-11 | 開始されました | H.C. Wainwright | Buy |
| 2020-03-25 | 開始されました | ROTH Capital | Buy |
| 2019-07-11 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Immunic Inc (IMUX) 最新ニュース
Earnings Update: Whats the analyst consensus on Immunic IncDay Trade & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
HC Wainwright Has Bearish Estimate for Immunic Q1 Earnings - MarketBeat
Dentons Advises Immunic, Inc. on Private Placement and Royalty Transactions - Dentons
IMUX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Immunic to present at healthcare investor conferences in March - Yahoo Finance
Immunic to Participate in Investor Conferences in March - ChartMill
Head to Head Review: Neuphoria Therapeutics and Immunic - National Today
Reverse stock split vote at Immunic (NASDAQ: IMUX) tied to Nasdaq listing - Stock Titan
Multiple Sclerosis Competitive Landscape 2026: 75+ Companies, 80+ Pipeline Therapies, 15+ Key FDA & Clinical Milestones Driving the Future of Multiple Sclerosis Treatment, analyses DelveInsight - Barchart.com
Immunic, Inc.Common Stock (NQ: IMUX - The Chronicle-Journal
H.C. Wainwright cuts Immunic stock price target on share count changes - Investing.com
HC Wainwright Issues Pessimistic Forecast for Immunic (NASDAQ:IMUX) Stock Price - MarketBeat
Aug Opening: Can Immunic Inc sustain earnings growthMarket Volume Summary & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Immunic (NASDAQ:IMUX) Posts Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Immunic secures $400M to support late-stage MS trialsICYMI - Proactive financial news
Trails Edge Capital Partners, LP Acquires Significant Stake in Immunic Inc - GuruFocus
BVF group details large Immunic (IMUX) pre-funded and common warrants - Stock Titan
IMMUNIC (IMUX) director Robert Nagel files initial insider Form 3 - Stock Titan
Immunic CEO on $400m financing, phase 3 MS plans - Proactive financial news
Immunic sets stage for phase 3 MS data readout after $400M financing - Yahoo Finance
Immunic: Fourth Quarter Financial Overview - Bitget
IMMUNIC, INC. SEC 10-K Report - TradingView
Immunic: Q4 Earnings Snapshot - Barchart.com
Immunic (NASDAQ: IMUX) details 2025 loss and $200M private placement - Stock Titan
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update - PR Newswire
Immunic, Inc. (NASDAQ:IMUX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Analysts Offer Insights on Healthcare Companies: ProQR (PRQR), Immunic (IMUX) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
Commodore holds 13.35M IMUX shares, mostly warrant-based (IMUX) - Stock Titan
Trails Edge reports 11.45M-share position in Immunic (IMUX) via warrants - Stock Titan
Why did IMUX stock surge 33% pre-market today? - MSN
IMUX Stock Price, Forecast & Analysis | IMMUNIC INC (NASDAQ:IMUX) - ChartMill
What’s the beta of Immunic Inc. stock2025 Earnings Impact & Long-Term Investment Growth Plans - mfd.ru
Why Immunic Inc. stock is seen as undervaluedJuly 2025 Macro Moves & Safe Entry Trade Reports - mfd.ru
Vivo Opportunity files for Immunic (IMUX): 9.99% stakes via exercisable warrants - Stock Titan
What Does the Market Think About Immunic Inc? - Benzinga
Immunic Therapeutics - The Pharma Letter
Immunic (IMUX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Immunic rises after $400M private placement, leadership transition - MSN
Immunic closes $200 million financing, may receive additional $200m By Investing.com - Investing.com Australia
Funding to support Immunic Phase 3 MS trials, commercialization - Multiple Sclerosis News Today
Immunic closes $200 million private placement - The Pharma Letter
Immunic closes $200 million financing, may receive additional $200m - Investing.com
Immunic closes $200M private placement to fund late-stage MS trials - Yahoo! Finance Canada
Immunic AG / US4525EP1011 - AD HOC NEWS
Immunic Announces Closing of Oversubscribed Private Placement Financing - PR Newswire
How Immunic Inc. stock reacts to global recession fearsJuly 2025 WrapUp & Reliable Intraday Trade Plans - mfd.ru
VIX Spike: Is Immunic Inc stock a good dividend stockWeekly Gains Report & Safe Entry Zone Identification - baoquankhu1.vn
Immunic, Inc. announced that it has received $200.010837 million in funding from a group of investors - marketscreener.com
Immunic (IMUX) Is Up 27.8% After Securing Oversubscribed $400M Raise For MS Push – What's Changed - simplywall.st
A Look At Immunic (IMUX) Valuation After Oversubscribed Funding And Leadership Changes - Yahoo Finance
Biogen Appoints Dr. Gabriela Freire as Board Chair While Immunic Inc. Searches for New CEO - geneonline.com
Immunic Inc (IMUX) 財務データ
収益
当期純利益
現金流量
EPS
Immunic Inc (IMUX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):